From co-pay assistance cards, vouchers, and coupons to leading-edge digital and mobile adherence marketing techniques, ConnectiveRx (formerly known as PSKW) is the market leader and innovation driver in pharmaceutical loyalty relationship marketing. The ConnectiveRx team works as a strategic partner with brand teams to effectively and efficiently build patient payment solutions, while driving medication trial, compliance, and adherence.

Foresite Capital believes that ConnectiveRx’s technology will continue to add value for both the drug manufacturers seeking to ensure patient access, and the patients who benefit from improved outcomes through medication adherence. ConnectiveRx is also uniquely positioned to capitalize on the growth in approved specialty medications, and Foresite expects ConnectiveRx will gain new large pharmaceutical company clients as patient access and affordability is brought into focus.